Published in Fertil Steril on September 11, 2013
Review of nonalcoholic fatty liver disease in women with polycystic ovary syndrome. World J Gastroenterol (2014) 0.89
Nonalcoholic fatty liver disease and polycystic ovary syndrome. World J Gastroenterol (2014) 0.84
Pediatric non-alcoholic fatty liver disease: Recent solutions, unresolved issues, and future research directions. World J Gastroenterol (2016) 0.78
Hepatic Steatosis is Common in Adolescents with Obesity and PCOS and Relates to De Novo Lipogenesis but not Insulin Resistance. Obesity (Silver Spring) (2016) 0.75
Reproductive history and chronic hepatic steatosis in the Michigan Study of Women's Health Across the Nation. J Womens Health (Larchmt) (2014) 0.75
Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology (2004) 18.86
The natural history of nonalcoholic fatty liver disease: a population-based cohort study. Gastroenterology (2005) 15.74
Long-term follow-up of patients with NAFLD and elevated liver enzymes. Hepatology (2006) 10.05
Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. Diabetes (2001) 9.67
Human fatty liver disease: old questions and new insights. Science (2011) 8.03
The prevalence and features of the polycystic ovary syndrome in an unselected population. J Clin Endocrinol Metab (2004) 7.96
Prevalence of fatty liver in children and adolescents. Pediatrics (2006) 7.00
Fat accumulation in the liver is associated with defects in insulin suppression of glucose production and serum free fatty acids independent of obesity in normal men. J Clin Endocrinol Metab (2002) 6.79
The natural history of nonalcoholic steatohepatitis: a follow-up study of forty-two patients for up to 21 years. Hepatology (1990) 6.53
Calculation of substrate oxidation rates in vivo from gaseous exchange. J Appl Physiol Respir Environ Exerc Physiol (1983) 6.45
Nonalcoholic steatohepatitis: an expanded clinical entity. Gastroenterology (1994) 5.22
Prevalence of the metabolic syndrome in American adolescents: findings from the Third National Health and Nutrition Examination Survey. Circulation (2004) 4.58
Metabolic syndrome rates in United States adolescents, from the National Health and Nutrition Examination Survey, 1999-2002. J Pediatr (2007) 3.64
Fatty liver hepatitis (steatohepatitis) and obesity: an autopsy study with analysis of risk factors. Hepatology (1990) 3.63
Liver pathology and the metabolic syndrome X in severe obesity. J Clin Endocrinol Metab (1999) 3.00
Effect of calorie restriction with or without exercise on insulin sensitivity, beta-cell function, fat cell size, and ectopic lipid in overweight subjects. Diabetes Care (2006) 2.86
Growth and maturation during adolescence. Nutr Rev (1981) 2.78
Proton MR spectroscopy in quantitative in vivo determination of fat content in human liver steatosis. J Magn Reson Imaging (1995) 2.77
Quantitative assessment of liver fat with magnetic resonance imaging and spectroscopy. J Magn Reson Imaging (2011) 2.75
Adolescent girls with polycystic ovary syndrome have an increased risk of the metabolic syndrome associated with increasing androgen levels independent of obesity and insulin resistance. J Clin Endocrinol Metab (2005) 2.50
Relationship between hepatic/visceral fat and hepatic insulin resistance in nondiabetic and type 2 diabetic subjects. Gastroenterology (2007) 2.50
Nonalcoholic steatohepatitis: a study of 49 patients. Hum Pathol (1989) 2.26
Abdominal fat distribution and peripheral and hepatic insulin resistance in type 2 diabetes mellitus. Am J Physiol Endocrinol Metab (2002) 2.08
Diagnosis of fatty liver disease: is biopsy necessary? Eur J Gastroenterol Hepatol (2003) 2.01
Noninvasive in vivo quantitative assessment of fat content in human liver. J Hepatol (1997) 1.92
Glucose intolerance in obese adolescents with polycystic ovary syndrome: roles of insulin resistance and beta-cell dysfunction and risk of cardiovascular disease. J Clin Endocrinol Metab (2001) 1.79
Nonalcoholic fatty liver disease in women with polycystic ovary syndrome. J Hepatol (2007) 1.78
Visceral fat and liver fat are independent predictors of metabolic risk factors in men. Am J Physiol Endocrinol Metab (2003) 1.76
Nonalcoholic fatty liver disease: a manifestation of the metabolic syndrome. Cleve Clin J Med (2008) 1.72
Screening for abnormal glucose tolerance in adolescents with polycystic ovary syndrome. J Clin Endocrinol Metab (2002) 1.63
Difference between liver and spleen CT numbers in the normal adult: its usefulness in predicting the presence of diffuse liver disease. Radiology (1980) 1.63
Race and gender differences in the relationships between anthropometrics and abdominal fat in youth. Obesity (Silver Spring) (2008) 1.56
Exercise and non-alcoholic fatty liver disease: a systematic review and meta-analysis. J Hepatol (2012) 1.52
In vivo insulin sensitivity and lipoprotein particle size and concentration in black and white children. Diabetes Care (2009) 1.46
Exercise alone reduces insulin resistance in obese children independently of changes in body composition. J Clin Endocrinol Metab (2007) 1.46
Detecting insulin resistance in polycystic ovary syndrome: purposes and pitfalls. Obstet Gynecol Surv (2004) 1.45
Diet and exercise interventions reduce intrahepatic fat content and improve insulin sensitivity in obese older adults. Obesity (Silver Spring) (2009) 1.33
Liver-fat accumulation and insulin resistance in obese women with previous gestational diabetes. Obes Res (2002) 1.31
A 12-week aerobic exercise program reduces hepatic fat accumulation and insulin resistance in obese, Hispanic adolescents. Obesity (Silver Spring) (2009) 1.29
Alterations in fatty acid kinetics in obese adolescents with increased intrahepatic triglyceride content. Obesity (Silver Spring) (2008) 1.27
Early metabolic abnormalities in adolescent girls with polycystic ovarian syndrome. J Pediatr (2001) 1.23
Randomized trial of exercise effect on intrahepatic triglyceride content and lipid kinetics in nonalcoholic fatty liver disease. Hepatology (2012) 1.18
Nonalcoholic steatohepatitis and nonalcoholic Fatty liver disease in young women with polycystic ovary syndrome. J Clin Endocrinol Metab (2006) 1.11
Systematic review: association of polycystic ovary syndrome with metabolic syndrome and non-alcoholic fatty liver disease. Aliment Pharmacol Ther (2011) 1.07
Correlations between fatty acid and glucose metabolism. Potential explanation of insulin resistance of puberty. Diabetes (1994) 1.05
Prevalence of nonalcoholic fatty liver disease in women with polycystic ovary syndrome. Clin Gastroenterol Hepatol (2007) 1.03
Nonalcoholic steatohepatitis in obesity: a reversible condition. Acta Med Scand (1986) 1.01
Exercise and the liver: implications for therapy in fatty liver disorders. Semin Liver Dis (2012) 0.99
An association between non-alcoholic fatty liver disease and polycystic ovarian syndrome. J Gastroenterol Hepatol (2009) 0.95
Whole-body substrate metabolism is associated with disease severity in patients with non-alcoholic fatty liver disease. Gut (2012) 0.94
Fatty liver index in polycystic ovary syndrome. Eur J Endocrinol (2011) 0.88
Abnormal aminotransferase activity in women with polycystic ovary syndrome. Fertil Steril (2005) 0.87
Drospirenone/ethinyl estradiol versus rosiglitazone treatment in overweight adolescents with polycystic ovary syndrome: comparison of metabolic, hormonal, and cardiovascular risk factors. J Clin Endocrinol Metab (2011) 0.86
Sonographic measurement of mesenteric fat predicts presence of fatty liver among subjects with polycystic ovary syndrome. J Clin Endocrinol Metab (2010) 0.84
Abnormal serum alanine aminotransferase levels are associated with impaired insulin sensitivity in young women with polycystic ovary syndrome. J Endocrinol Invest (2009) 0.84
Hepatic steatosis in young lean insulin resistant women with polycystic ovary syndrome. Fertil Steril (2009) 0.82
Increased visceral adipocyte lipolysis--a pathogenic role in nonalcoholic fatty liver disease? J Clin Endocrinol Metab (2010) 0.80
Validation of a novel index to assess insulin resistance of adipose tissue lipolytic activity in obese subjects. J Lipid Res (2011) 0.80
Metabolic manifestations of polycystic ovary syndrome in nonobese adolescents: retinol-binding protein 4 and ectopic fat deposition. Fertil Steril (2012) 0.79
A clinical trial to maintain glycemic control in youth with type 2 diabetes. N Engl J Med (2012) 7.51
The metabolic syndrome in children and adolescents. Lancet (2007) 5.97
The metabolic syndrome in children and adolescents - an IDF consensus report. Pediatr Diabetes (2007) 4.84
Validation of surrogate estimates of insulin sensitivity and insulin secretion in children and adolescents. J Pediatr (2004) 2.66
Childhood obesity predicts adult metabolic syndrome: the Fels Longitudinal Study. J Pediatr (2007) 2.07
Effect of metformin in pediatric patients with type 2 diabetes: a randomized controlled trial. Diabetes Care (2002) 1.88
Oral disposition index in obese youth from normal to prediabetes to diabetes: relationship to clamp disposition index. J Pediatr (2012) 1.82
Youth type 2 diabetes: insulin resistance, beta-cell failure, or both? Diabetes Care (2005) 1.78
The presence of GAD and IA-2 antibodies in youth with a type 2 diabetes phenotype: results from the TODAY study. Diabetes Care (2010) 1.76
Insulin resistance in children: consensus, perspective, and future directions. J Clin Endocrinol Metab (2010) 1.73
Comparison of different definitions of pediatric metabolic syndrome: relation to abdominal adiposity, insulin resistance, adiponectin, and inflammatory biomarkers. J Pediatr (2007) 1.66
Phenotypic type 2 diabetes in obese youth: insulin sensitivity and secretion in islet cell antibody-negative versus -positive patients. Diabetes (2008) 1.64
Insulin resistance: link to the components of the metabolic syndrome and biomarkers of endothelial dysfunction in youth. Diabetes Care (2007) 1.62
Early signs of cardiovascular disease in youth with obesity and type 2 diabetes. Diabetes Care (2005) 1.43
Skeletal muscle lipid content and insulin sensitivity in black versus white obese adolescents: is there a race differential? J Clin Endocrinol Metab (2010) 1.30
Type 2 diabetes mellitus in youth: the complete picture to date. Pediatr Clin North Am (2005) 1.24
Surrogate estimates of insulin sensitivity in obese youth along the spectrum of glucose tolerance from normal to prediabetes to diabetes. J Clin Endocrinol Metab (2011) 1.21
From pre-diabetes to type 2 diabetes in obese youth: pathophysiological characteristics along the spectrum of glucose dysregulation. Diabetes Care (2010) 1.21
Declining beta-cell function relative to insulin sensitivity with increasing fasting glucose levels in the nondiabetic range in children. Diabetes Care (2010) 1.19
Type 2 diabetes in youth: are there racial differences in β-cell responsiveness relative to insulin sensitivity? Pediatr Diabetes (2011) 1.18
Progression from normal glucose tolerance to type 2 diabetes in a young girl: longitudinal changes in insulin sensitivity and secretion assessed by the clamp technique and surrogate estimates. Pediatr Diabetes (2005) 1.13
Progressive beta cell failure in type 2 diabetes mellitus of youth. J Pediatr (2004) 1.13
Whole-body MRI and ethnic differences in adipose tissue and skeletal muscle distribution in overweight black and white adolescent boys. J Obes (2011) 1.12
Declining β-cell function relative to insulin sensitivity with escalating OGTT 2-h glucose concentrations in the nondiabetic through the diabetic range in overweight youth. Diabetes Care (2011) 1.11
Sleep-disordered breathing in obese adolescents is associated with visceral adiposity and markers of insulin resistance. Int J Pediatr Obes (2010) 1.06
Insulin glargine versus intermediate-acting insulin as the basal component of multiple daily injection regimens for adolescents with type 1 diabetes mellitus. J Pediatr (2008) 1.04
Islet cell antibody-positive versus -negative phenotypic type 2 diabetes in youth: does the oral glucose tolerance test distinguish between the two? Diabetes Care (2009) 1.04
Treatment of PCOS in adolescence. Best Pract Res Clin Endocrinol Metab (2006) 1.01
Determinants of glycemic control in youth with type 2 diabetes at randomization in the TODAY study. Pediatr Diabetes (2012) 1.01
Detection of expressed IL-32 in human stomach cancer using ELISA and immunostaining. J Microbiol Biotechnol (2008) 0.97
Metabolomic profiling of amino acids and β-cell function relative to insulin sensitivity in youth. J Clin Endocrinol Metab (2012) 0.97
Progressive deterioration of β-cell function in obese youth with type 2 diabetes. Pediatr Diabetes (2012) 0.96
Aerobic exercise but not resistance exercise reduces intrahepatic lipid content and visceral fat and improves insulin sensitivity in obese adolescent girls: a randomized controlled trial. Am J Physiol Endocrinol Metab (2013) 0.94
Implications of type 2 diabetes on adolescent reproductive health risk: an expert model. Diabetes Educ (2010) 0.91
Treatment of type 2 diabetes in youth. Diabetes Care (2011) 0.91
Pathophysiology of type 2 diabetes mellitus in youth: the evolving chameleon. Arq Bras Endocrinol Metabol (2009) 0.91
The Diagnosis of Polycystic Ovary Syndrome during Adolescence. Horm Res Paediatr (2015) 0.90
HbA(1c) diagnostic categories and β-cell function relative to insulin sensitivity in overweight/obese adolescents. Diabetes Care (2012) 0.89
Type 2 diabetes in childhood: the American perspective. Horm Res (2003) 0.87
Drospirenone/ethinyl estradiol versus rosiglitazone treatment in overweight adolescents with polycystic ovary syndrome: comparison of metabolic, hormonal, and cardiovascular risk factors. J Clin Endocrinol Metab (2011) 0.86
Fasting and 2-hour plasma glucose and insulin: relationship with risk factors for cardiovascular disease in overweight nondiabetic children. Diabetes Care (2010) 0.86
One-hour plasma glucose concentration during the OGTT: what does it tell about β-cell function relative to insulin sensitivity in overweight/obese children? Pediatr Diabetes (2011) 0.85
Epiregulin expression by Ets-1 and ERK signaling pathway in Ki-ras-transformed cells. Biochem Biophys Res Commun (2008) 0.85
Comparison of glycemic variability associated with insulin glargine and intermediate-acting insulin when used as the basal component of multiple daily injections for adolescents with type 1 diabetes. Diabetes Care (2008) 0.84
Menstrual health and the metabolic syndrome in adolescents. Ann N Y Acad Sci (2008) 0.84
β-Cell lipotoxicity in response to free fatty acid elevation in prepubertal youth: African American versus Caucasian contrast. Diabetes (2013) 0.83
Measuring β-cell function relative to insulin sensitivity in youth: does the hyperglycemic clamp suffice? Diabetes Care (2012) 0.82
Liraglutide's safety, tolerability, pharmacokinetics, and pharmacodynamics in pediatric type 2 diabetes: a randomized, double-blind, placebo-controlled trial. Diabetes Technol Ther (2014) 0.82
Liver disease and other comorbidities in Wolcott-Rallison syndrome: different phenotype and variable associations in a large cohort. Horm Res Paediatr (2015) 0.82
Parental and offspring associations of the metabolic syndrome in the Fels Longitudinal Study. Am J Clin Nutr (2012) 0.81
Comparable efficacy and safety of insulin glulisine and insulin lispro when given as part of a Basal-bolus insulin regimen in a 26-week trial in pediatric patients with type 1 diabetes. Diabetes Technol Ther (2011) 0.80
Effects of an overnight intravenous lipid infusion on intramyocellular lipid content and insulin sensitivity in African-American versus Caucasian adolescents. Metabolism (2012) 0.79
A3 adenosine receptor antagonist, truncated Thio-Cl-IB-MECA, induces apoptosis in T24 human bladder cancer cells. Anticancer Res (2010) 0.79
Pathophysiology of type 2 diabetes mellitus in children and adolescents: treatment implications. Treat Endocrinol (2002) 0.78
Cross-sectional association between blood pressure, in vivo insulin sensitivity and adiponectin in overweight adolescents. Horm Res Paediatr (2011) 0.78
Profiling of transcripts and proteins modulated by the E7 oncogene in the lung tissue of E7-Tg mice by the omics approach. Mol Med Rep (2011) 0.77
Optimization of an enzyme-linked immunosorbent assay to screen ligand of Peroxisome proliferator-activated receptor alpha. Immunopharmacol Immunotoxicol (2009) 0.76
Indices of insulin secretion during a liquid mixed-meal test in obese youth with diabetes. J Pediatr (2013) 0.75
Dubowitz syndrome: common findings and peculiar urine odor. Appl Clin Genet (2013) 0.75
Melphalan modulates the expression of E7-specific biomarkers in E7-Tg mice. Anticancer Res (2010) 0.75
Role of physical activity in the treatment of nonalcoholic fatty liver disease in children and adolescents. Appl Physiol Nutr Metab (2013) 0.75